Interestingly, a heterodimerization between NTR1 and SORT1, leading to NT internalization, has been described in colonic adenocarcinoma cell lines [56], making NT/NTR1/SORT1 a potential therapeutic target for ovarian carcinoma. This evidence concerns the gene SORT1 and ovarian carcinoma.